trending Market Intelligence /marketintelligence/en/news-insights/trending/82vnR761gUo2jXAhmgry5g2 content esgSubNav
In This List

Bellicum Pharmaceuticals closes $69M stock offering

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push


Bellicum Pharmaceuticals closes $69M stock offering

Bellicum Pharmaceuticals Inc. closed its underwritten public offering of 5,750,000 common shares priced at $12 per share.

The amount includes 750,000 shares that were issued as part of an overallotment option fully exercised by underwriters.

All in all, the company raised $69 million with Citigroup and Jefferies acting as the lead book-running managers for the offering. Guggenheim Securities, Ladenburg Thalmann, Raymond James and SunTrust Robinson Humphrey acted as co-managers.